PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2347.86 Billion IDR | 14.7% |
| 2022 | 2047.04 Billion IDR | 12.87% |
| 2021 | 1813.62 Billion IDR | -8.13% |
| 2020 | 1974.14 Billion IDR | 0.97% |
| 2019 | 1955.09 Billion IDR | 23.52% |
| 2018 | 1582.87 Billion IDR | 0.97% |
| 2017 | 1567.73 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 2650.02 Billion IDR | -1.32% |
| 2024 Q1 | 2606.14 Billion IDR | 11.0% |
| 2024 Q2 | 2685.51 Billion IDR | 3.05% |
| 2023 Q4 | 2347.86 Billion IDR | 10.69% |
| 2023 FY | 2347.86 Billion IDR | 14.7% |
| 2023 Q3 | 2121.07 Billion IDR | -9.88% |
| 2023 Q2 | 2353.56 Billion IDR | 11.66% |
| 2023 Q1 | 2107.83 Billion IDR | 2.97% |
| 2022 Q3 | 2064.11 Billion IDR | 10.21% |
| 2022 Q2 | 1872.94 Billion IDR | -13.28% |
| 2022 Q1 | 2159.72 Billion IDR | 19.08% |
| 2022 FY | 2047.04 Billion IDR | 12.87% |
| 2022 Q4 | 2047.04 Billion IDR | -0.83% |
| 2021 Q4 | 1813.62 Billion IDR | -23.45% |
| 2021 Q3 | 2369.05 Billion IDR | 17.25% |
| 2021 Q2 | 2020.44 Billion IDR | 2.54% |
| 2021 Q1 | 1970.44 Billion IDR | -0.19% |
| 2021 FY | 1813.62 Billion IDR | -8.13% |
| 2020 Q4 | 1974.14 Billion IDR | 23.71% |
| 2020 Q1 | 2274.77 Billion IDR | 24.05% |
| 2020 FY | 1974.14 Billion IDR | 0.97% |
| 2020 Q3 | 1595.76 Billion IDR | 0.0% |
| 2019 Q4 | 1833.79 Billion IDR | 0.0% |
| 2019 FY | 1955.09 Billion IDR | 23.52% |
| 2019 Q1 | - IDR | 0.0% |
| 2018 FY | 1582.87 Billion IDR | 0.97% |
| 2017 FY | 1567.73 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 3658.01 Billion IDR | 35.816% |
| PT Itama Ranoraya Tbk | 599.68 Billion IDR | -291.516% |
| PT Kimia Farma (Persero) Tbk | 11418.56 Billion IDR | 79.438% |
| PT Millennium Pharmacon International Tbk | 1361.96 Billion IDR | -72.387% |